These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21853369)
1. Synthesis of monomethoxypolyethyleneglycol-cholesteryl ester and effect of its incorporation in liposomes. Sant VP; Nagarsenker MS AAPS PharmSciTech; 2011 Dec; 12(4):1056-63. PubMed ID: 21853369 [TBL] [Abstract][Full Text] [Related]
2. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729 [TBL] [Abstract][Full Text] [Related]
3. Prolonged blood circulation of methotrexate by modulation of liposomal composition. Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781 [TBL] [Abstract][Full Text] [Related]
4. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives. Moribe K; Maruyama K; Iwatsuru M Int J Pharm; 1999 Oct; 188(2):193-202. PubMed ID: 10518675 [TBL] [Abstract][Full Text] [Related]
5. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes. Moribe K; Maruyama K; Iwatsuru M Int J Pharm; 2000 May; 201(1):37-49. PubMed ID: 10867263 [TBL] [Abstract][Full Text] [Related]
6. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806 [TBL] [Abstract][Full Text] [Related]
7. PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies. Fernández-Carballido A; Pastoriza P; Barcia E; Montejo C; Negro S Int J Pharm; 2008 Mar; 352(1-2):50-7. PubMed ID: 18036755 [TBL] [Abstract][Full Text] [Related]
8. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting. Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537 [TBL] [Abstract][Full Text] [Related]
9. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes]. Liu H; Tang R; He XX; Zhang Y Yao Xue Xue Bao; 2002 Jul; 37(7):563-6. PubMed ID: 12914330 [TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909 [TBL] [Abstract][Full Text] [Related]
11. New amphiphilic derivatives of poly(ethylene glycol) (PEG) as surface modifiers of colloidal drug carriers. III. Lipoamino acid conjugates with carboxy- and amino-PEG(5000) polymers. Pignatello R; Impallomeni G; Pistarà V; Cupri S; Graziano AC; Cardile V; Ballistreri A Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():470-81. PubMed ID: 25492012 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629 [TBL] [Abstract][Full Text] [Related]
13. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase. Jin SE; Kim IS; Kim CK Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624 [TBL] [Abstract][Full Text] [Related]